QIAGEN NV's ticker is and the CUSIP is N72482AA5. A total of 16 filers reported holding QIAGEN NV in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 30,000,000 | $38,186,000 | 8.14% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 40,800,000 | $49,521,000 | 3.27% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 48,800,000 | $59,159,000 | 1.75% |
| EXANE DERIVATIVES | 11 | $2,634,132,000 | 0.47% |
| Verition Fund Management LLC | 50,000 | $5,972,000 | 0.43% |
| BlueCrest Capital Management Ltd | 6,600,000 | $7,893,000 | 0.41% |
| CQS Cayman LP | 4,200,000 | $5,015,000 | 0.34% |
| SG Americas Securities, LLC | 128,000 | $15,413,000 | 0.14% |
| OAKTREE CAPITAL MANAGEMENT LP | 4,400,000 | $5,252,000 | 0.05% |
| HSBC HOLDINGS PLC | 190,702 | $22,777,000 | 0.04% |